BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20403680)

  • 21. Activity of a novel sulfonamide compound 2-nitro-N-(pyridin-2-ylmethyl)benzenesulfonamide against Leishmania donovani.
    Dikhit MR; Purkait B; Singh R; Sahoo BR; Kumar A; Kar RK; Ansari MY; Saini S; Abhishek K; Sahoo GC; Das S; Das P
    Drug Des Devel Ther; 2016; 10():1753-61. PubMed ID: 27307706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro and in vivo activity of Aloe vera leaf exudate in experimental visceral leishmaniasis.
    Dutta A; Sarkar D; Gurib-Fakim A; Mandal C; Chatterjee M
    Parasitol Res; 2008 May; 102(6):1235-42. PubMed ID: 18266009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunotherapeutic Potential of Eugenol Emulsion in Experimental Visceral Leishmaniasis.
    Islamuddin M; Chouhan G; Want MY; Ozbak HA; Hemeg HA; Afrin F
    PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005011. PubMed ID: 27776125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Th1-biased immunomodulation and therapeutic potential of Artemisia annua in murine visceral leishmaniasis.
    Islamuddin M; Chouhan G; Farooque A; Dwarakanath BS; Sahal D; Afrin F
    PLoS Negl Trop Dis; 2015 Jan; 9(1):e3321. PubMed ID: 25568967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Withania somnifera chemotype NMITLI 101R significantly increases the efficacy of antileishmanial drugs by generating strong IFN-γ and IL-12 mediated immune responses in Leishmania donovani infected hamsters.
    Tripathi CD; Kushawaha PK; Sangwan RS; Mandal C; Misra-Bhattacharya S; Dube A
    Phytomedicine; 2017 Jan; 24():87-95. PubMed ID: 28160866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lupeol and amphotericin B mediate synergistic anti-leishmanial immunomodulatory effects in Leishmania donovani-infected BALB/c mice.
    Das A; Jawed JJ; Das MC; Parveen S; Ghosh C; Majumdar S; Saha B; Bhattacharjee S
    Cytokine; 2021 Jan; 137():155319. PubMed ID: 33002744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo experiments demonstrate the potent antileishmanial efficacy of repurposed suramin in visceral leishmaniasis.
    Khanra S; Juin SK; Jawed JJ; Ghosh S; Dutta S; Nabi SA; Dash J; Dasgupta D; Majumdar S; Banerjee R
    PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008575. PubMed ID: 32866156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiparasitic activity of a triphenyl tin complex against Leishmania donovani.
    Raychaudhury B; Banerjee S; Gupta S; Singh RV; Datta SC
    Acta Trop; 2005 Jul; 95(1):1-8. PubMed ID: 15896700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. β-Amino acid derivatives as mitochondrial complex III inhibitors of L. donovani: A promising chemotype targeting visceral leishmaniasis.
    Chandrakar P; Gunaganti N; Parmar N; Kumar A; Singh SK; Rashid M; Wahajuddin M; Mitra K; Narender T; Kar S
    Eur J Med Chem; 2019 Nov; 182():111632. PubMed ID: 31499363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluorinated rhodacyanine (SJL-01) possessing high efficacy for visceral leishmaniasis (VL).
    Yang M; Arai C; Bakar Md A; Lu J; Ge JF; Pudhom K; Takasu K; Kasai K; Kaiser M; Brun R; Yardley V; Itoh I; Ihara M
    J Med Chem; 2010 Jan; 53(1):368-73. PubMed ID: 19894726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral Therapy with Amlodipine and Lacidipine, 1,4-Dihydropyridine Derivatives Showing Activity against Experimental Visceral Leishmaniasis.
    Palit P; Ali N
    Antimicrob Agents Chemother; 2008 Jan; 52(1):374-7. PubMed ID: 17954702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on the protective and immunomodulatory efficacy of Withania somnifera along with cisplatin against experimental visceral leishmaniasis.
    Sachdeva H; Sehgal R; Kaur S
    Parasitol Res; 2013 Jun; 112(6):2269-80. PubMed ID: 23519426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The leishmanicidal activity of oleuropein is selectively regulated through inflammation- and oxidative stress-related genes.
    Kyriazis ID; Koutsoni OS; Aligiannis N; Karampetsou K; Skaltsounis AL; Dotsika E
    Parasit Vectors; 2016 Aug; 9(1):441. PubMed ID: 27501956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Curative efficacy of purified serine protease inhibitor PTF3 from potato tuber in experimental visceral leishmaniasis.
    Paik D; Pramanik PK; Chakraborti T
    Int Immunopharmacol; 2020 Aug; 85():106623. PubMed ID: 32504996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro and in vivo antileishmanial efficacy of nitazoxanide against Leishmania donovani.
    Zhang R; Shang L; Jin H; Ma C; Wu Y; Liu Q; Xia Z; Wei F; Zhu XQ; Gao H
    Parasitol Res; 2010 Jul; 107(2):475-9. PubMed ID: 20495931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel outlook in the delivery of artemisinin: production and efficacy in experimental visceral leishmaniasis.
    Akbari M; Heli H; Oryan A; Hatam G
    Pathog Glob Health; 2024 Feb; 118(1):40-46. PubMed ID: 37183476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CpG oligodeoxynucleotide augments the antileishmanial activity of miltefosine against experimental visceral leishmaniasis.
    Sane SA; Shakya N; Haq W; Gupta S
    J Antimicrob Chemother; 2010 Jul; 65(7):1448-54. PubMed ID: 20495208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sertraline Delivered in Phosphatidylserine Liposomes Is Effective in an Experimental Model of Visceral Leishmaniasis.
    Romanelli MM; da Costa-Silva TA; Cunha-Junior E; Dias Ferreira D; Guerra JM; Galisteo AJ; Pinto EG; Barbosa LRS; Torres-Santos EC; Tempone AG
    Front Cell Infect Microbiol; 2019; 9():353. PubMed ID: 31737574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The lignan niranthin poisons Leishmania donovani topoisomerase IB and favours a Th1 immune response in mice.
    Chowdhury S; Mukherjee T; Mukhopadhyay R; Mukherjee B; Sengupta S; Chattopadhyay S; Jaisankar P; Roy S; Majumder HK
    EMBO Mol Med; 2012 Oct; 4(10):1126-43. PubMed ID: 23027614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ivermectin presents effective and selective antileishmanial activity in vitro and in vivo against Leishmania infantum and is therapeutic against visceral leishmaniasis.
    Reis TAR; Oliveira-da-Silva JA; Tavares GSV; Mendonça DVC; Freitas CS; Costa RR; Lage DP; Martins VT; Machado AS; Ramos FF; Silva AM; Ludolf F; Antinarelli LMR; Brito RCF; Chávez-Fumagalli MA; Humbert MV; Roatt BM; Coimbra ES; Coelho EAF
    Exp Parasitol; 2021 Feb; 221():108059. PubMed ID: 33338468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.